Skip to main content
Signal8

BLICKENSTAFF KIM D

SEC insider (Form 3/4/5 filer). CIK 0001238913. Director at Nuvation Bio Inc. (NUVB) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in SAN DIEGO, CA.

Companies BLICKENSTAFF KIM D has filed insider reports for

  • Nuvation Bio Inc. (NUVB): Director
  • TANDEM DIABETES CARE INC (TNDM): Director
BLICKENSTAFF KIM D profile photo

BLICKENSTAFF KIM D

CIK: 0001238913

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Nuvation Bio Inc. logo
NUVB

Nuvation Bio Inc.

Director
TANDEM DIABETES CARE INC logo
TNDM

TANDEM DIABETES CARE INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Nuvation Bio Inc. logo
    NUVB

    Nuvation Bio Inc.

    May 21, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    123.4K shares-
  • Nuvation Bio Inc. logo
    NUVB

    Nuvation Bio Inc.

    May 21, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    293K shares-
  • TANDEM DIABETES CARE INC logo
    TNDM

    TANDEM DIABETES CARE INC

    Nov 21, 2024
    Sale
    Indirect
    30K shares at avg. $31.38$941K
  • TANDEM DIABETES CARE INC logo
    TNDM

    TANDEM DIABETES CARE INC

    Nov 20, 2024
    Sale
    Indirect
    10K shares at avg. $30.00$300K
  • Nuvation Bio Inc. logo
    NUVB

    Nuvation Bio Inc.

    Sep 3, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    200.8K shares-

1-5 of 5